Fight against COVID-19 but avoid disruption of services for other communicable diseases (CDs) and noncommunicable diseases (NCDs)-Reference-Cited by-同舟云学术

Fight against COVID-19 but avoid disruption of services for other communicable diseases (CDs) and noncommunicable diseases (NCDs)

Published:2020-12-31 Issue:6 Volume:2 Page:343-345
ISSN:2434-9186
Container-title:Global Health & Medicine
language:en
Short-container-title:GHM

Author:

Mitsuya Hiroaki¹

Affiliation:

1. Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Publisher

National Center for Global Health and Medicine (JST)

Link

https://www.jstage.jst.go.jp/article/ghm/2/6/2_2020.01111/_pdf

Reference6 articles.

1. 1. IHME, GHDx, Viz Hub. Global Both sexes, All ages, 2019, DALYs. https://ihmeuw.org/3pms (accessed December 12, 2020).

2. 2. IHME, GHDx, Viz Hub. Global Both sexes, All ages, 2019, DALYs. http://ihmeuw.org/3pmt (accessed December 12, 2020).

3. 3. World Health Organization. Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (accessed December 13, 2020).

4. 4. World Life Expectancy. World Total Deaths. https://www.worldlifeexpectancy.com/world-rankings-total-deaths (accessed December 13, 2020).

5. 5. ReliefWeb. COVID-19 significantly impacts health services for noncommunicable diseases. https://reliefweb.int/report/world/covid-19-significantly-impacts-health-services-noncommunicable-diseases (accessed December 15, 2020).

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in lifestyle-related behaviour during the COVID-19 pandemic in Japan: a questionnaire survey for examinees who underwent an annual health check-up;Journal of International Medical Research;2023-07

2. Impact of COVID-19 pandemic and anti-pandemic measures on tuberculosis, viral hepatitis, HIV/AIDS and malaria–A systematic review;PLOS Global Public Health;2023-05-01

3. Emergency medical service planning considering dynamic and stochastic demands of infected and non-infected patients during epidemics;Journal of the Operational Research Society;2023-04-18

4. Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2;Nature Communications;2023-02-25

5. Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan;Human Vaccines & Immunotherapeutics;2023-01-02